DarioHealth today priced an underwritten public offering of 4.8 million shares of common stock at 60¢ per share with additional pre-funded warrants. Pre-funded warrants offer 7.2 million shares of common stock at 59¢ each for gross proceeds of roughly $7.2 million. Get the full story on our sister site, Drug Delivery Business.
DarioHealth touts updated diabetes management software
DarioHealth (NSDQ:DRIO) said yesterday it launched a new version of its Dario system and DarioEngage platform. The new V4.2.0 update to both digital health programs are intended to improve user engagement, lower barriers to behavioral change and to streamline the experience and process efficiency for both users and their coaches, the Israel-based company said. Read the whole […]
DarioHealth, Glytec ink joint marketing deal
DarioHealth (NSDQ:DRIO) said today it inked a joint marketing agreement with Glytec through which DarioHealth’s smart glucose meter will be able to transmit information to Glytec’s Glucommander Outpatient software. Israel-based DarioHealth said that blood glucose data from its Dario Blood Glucose Monitoring System will now be imported into the Glucommander Outpatient for use in conjunction with […]
DarioHealth inks U.S. distro deal for digital glucose meter
DarioHealth (NSDQ:DRIO) said today that it inked a deal with healthcare products provider Better Living Now for the distribution of its blood glucose monitoring system and the DarioEngage digital health program. According to the terms of the deal, BLN plans to buy DarioHealth’s smart glucose meter and test strips to distribute to its customers. The agreement […]
DarioHealth raises $10m in private offering
DarioHealth (NSDQ:DRIO) said today that it closed a private placement offering with institutional and private investors, bringing in roughly $10.3 million for the Israel-based company. As part of the private placement, DarioHealth issued 4,266,800 shares of common stock at 90¢ apiece and 1,806,923 shares of Series D convertible preferred stock at $3.60 apiece. The company also offered […]
Amazon-Berkshire-JPM healthcare bet taps Comcast’s Stoddard for COO | Personnel Moves, Sept. 10, 2018
Amazon-Berkshire-JPM healthcare bet taps Comcast’s Stoddard for COO The healthcare joint venture started by Amazon (NSDQ:AMZN), Berkshire Hathaway and J.P. Morgan tapped former Comcast executive Jack Stoddard to be its COO, reporting to CEO Dr. Atul Gawande. Stoddard was a co-founder of Accolade, a startup backed by the cable giant that helps workers manage their health […]
DarioHealth wins FDA nod for iPhone-compatible glucose meter
The FDA cleared DarioHealth‘s (NSDQ:DRIO) iPhone-compatible blood glucose monitoring system, enabling users to access the company’s Dario app on iPhone 7, 8 and X mobile devices. The Israel-based company’s product is designed to work with Apple’s latest smartphones, which feature a Lightning connector in place of a standard headphone jack. Get the full story at our […]
DarioHealth launches Dario blood glucose monitor on Amazon
DarioHealth (NSDQ:DRIO) said today it launched its Dario blood glucose monitoring system on the Amazon marketplace, touting that the system has already been sold through the site. The company’s blood glucose monitor, which syncs with Dario’s diabetes management app, connects via a headphone jack to a mobile device, helping diabetes patients monitor their blood glucose throughout the day. The […]
Diabetes clinic taps DarioHealth for blood glucose monitoring tech
DarioHealth (NSDQ:DRIO) has partnered with the Diabetes and Endocrinology Consultants of Pennsylvania to bring its blood glucose monitoring system to the 5,000-patient facility. The company’s blood glucose monitor, which syncs with Dario’s diabetes management app, connects via a headphone jack to a mobile device, helping diabetes patients monitor their blood glucose throughout the day. The app also records […]
DarioHealth inks deal to use blood glucose tech in pharma company’s clinical trial
DarioHealth (NSDQ:DRIO) said today that it inked a deal with an unnamed pharmaceutical company to combine its blood glucose monitoring tech into the company’s clinical trial. The Israel-based device-maker reported that this pharmaceutical company is conducting a trial of its diabetes drug that will eventually be included in a regulatory package for FDA approval. Get the […]
DarioHealth launches iPhone-compatible glucose meter in Australia
DarioHealth (NSDQ:DRIO) said today that the Lightning-enabled version of its blood glucose monitoring system is available in Australia. The device is designed to connect with the latest Apple products, including the iPhone 7, iPhone 8 and iPhone X. The product’s launch comes just one month after it won approval from Australian authorities. Get the full story at […]
MassDevice Network
@MassDevice
LinkedIn
YouTube